A celiac panel is a set of blood tests that checks for specific antibodies your immune system produces when it reacts to gluten. It’s the primary screening tool for celiac disease, and it typically requires just a single blood draw. The exact combination of tests varies by lab, but most panels center on one key antibody test, with others added to confirm or clarify the results.
Tests Included in a Celiac Panel
The cornerstone of every celiac panel is the tissue transglutaminase IgA test, commonly written as tTG-IgA on lab reports. This is the preferred first-line screening test for most people. It detects antibodies that target an enzyme in the lining of your small intestine, which is the tissue celiac disease damages. When gluten triggers an immune response, levels of these antibodies rise in the blood.
Beyond tTG-IgA, panels may include some or all of the following:
- Total serum IgA: This measures your overall level of a particular type of antibody (immunoglobulin A). About 2 to 3 percent of people with celiac disease are IgA-deficient, meaning their bodies don’t produce enough of it. If your total IgA is low, the tTG-IgA test can come back falsely negative because there simply isn’t enough of that antibody class to detect.
- Endomysial antibody IgA (EMA-IgA): This test targets antibodies against the connective tissue surrounding muscle fibers in the gut. It’s highly specific, meaning a positive result almost certainly points to celiac disease. It’s often used as a confirmation step after a positive tTG-IgA.
- Deamidated gliadin peptide IgG and IgA (DGP-IgG and DGP-IgA): These tests detect antibodies against fragments of gluten itself. The IgG version is especially important for people with IgA deficiency, since it relies on a different antibody class that isn’t affected by low IgA levels.
- tTG-IgG: Another backup test useful when IgA deficiency is present.
Not every lab runs all of these at once. Some labs use a cascade approach: they start with tTG-IgA and total IgA, then only run additional tests if the initial results are ambiguous or if IgA deficiency is detected. Others bundle several tests together from the start. What shows up on your lab order depends on the lab your provider uses and the clinical situation.
How to Read Your Results
Celiac antibody results are reported in units per milliliter (U/mL), with each lab setting its own reference range. As a general example, some labs use a cutoff below 4.0 U/mL as negative and flag values between 4.0 and 10.0 U/mL as borderline. Values above the upper limit are considered positive. Your lab report will include the specific reference range next to each result, so look for whether your number falls in the “negative,” “weak positive,” or “positive” category defined by that particular lab.
The strength of a positive result matters. The American Gastroenterological Association notes that when tTG-IgA levels are more than 10 times the upper limit of normal and an EMA test is also positive on a second blood sample, the positive predictive value for celiac disease is virtually 100 percent. Lower positive values still warrant follow-up but are less definitive on their own.
A negative result on the full panel makes celiac disease unlikely but doesn’t completely rule it out, particularly in young children. For symptomatic children under age 2 with risk factors like a family history of celiac disease, a small intestinal biopsy may still be recommended even if blood tests come back negative, because antibody levels can be unreliable at that age.
Why You Need to Be Eating Gluten
This is the detail that catches many people off guard: a celiac panel only works if you’ve been eating gluten regularly before the test. The antibodies the panel detects are produced in response to gluten exposure. If you’ve already cut gluten from your diet, your antibody levels may have dropped to normal, and the test will appear negative even if you have celiac disease.
If you’ve already gone gluten-free and need accurate testing, you’ll need what’s called a gluten challenge. This typically means eating the equivalent of one to five slices of bread worth of gluten (roughly 3 to 10 grams) every day for six to eight weeks before blood is drawn. That’s enough to provoke a measurable antibody response if celiac disease is present. If you can’t tolerate the full challenge period because of severe symptoms, recent evidence suggests that even two weeks of daily gluten consumption may be enough to produce useful biopsy results, though antibody tests may still need the longer window.
What Happens After a Positive Panel
In most adults, a positive celiac panel is followed by an upper endoscopy with biopsies of the small intestine. During this procedure, a gastroenterologist takes small tissue samples from the duodenum (the first section of the small intestine) to look for the characteristic damage celiac disease causes: flattening of the tiny finger-like projections called villi that line the intestinal wall. This biopsy has traditionally been considered the gold standard for confirming the diagnosis.
Current guidelines from both the American College of Gastroenterology and the AGA recommend this biopsy confirmation for adults in most circumstances. However, when tTG-IgA levels are very high (more than 10 times the upper limit of normal) and a separate EMA test is also positive, some clinicians may consider the diagnosis confirmed without biopsy, an approach that’s been more widely adopted in pediatric practice in Europe.
The Role of Genetic Testing
Some celiac panels or follow-up testing includes genetic markers called HLA-DQ2 and HLA-DQ8. These aren’t diagnostic on their own. Roughly 30 to 40 percent of the general population carries one or both of these gene variants, and most of them never develop celiac disease. What makes genetic testing useful is its negative predictive value: if you don’t carry either gene variant, celiac disease is essentially ruled out. This makes the test most helpful in uncertain situations, such as when someone has already gone gluten-free before testing, when biopsy results are ambiguous, or when screening family members to determine who needs ongoing monitoring.
Who Should Get Tested
A celiac panel is typically ordered for people with symptoms like chronic diarrhea, bloating, unexplained weight loss, iron-deficiency anemia that doesn’t respond to supplements, or persistent fatigue. It’s also recommended for people with a first-degree relative (parent, sibling, or child) who has celiac disease, since the condition has a strong genetic component. People with type 1 diabetes, autoimmune thyroid disease, or Down syndrome also have higher rates of celiac disease and may benefit from screening even without obvious digestive symptoms.
Celiac disease affects roughly 1 in 100 people worldwide, but the majority remain undiagnosed, partly because symptoms can be subtle or appear unrelated to digestion. The celiac panel is a straightforward, minimally invasive first step that can either point toward a diagnosis or provide reassurance, as long as you’re eating gluten when the blood is drawn.